Netherlands· NL-98a1573e283c
Dexagenta-POS, oogdruppels 1 en 5 mg/ml
A dexamethason mit antiinfektiva product containing dexamethasondinatriumfosfaat + gentamicinesulfaat, registered in Netherlands by URSAPHARM Benelux B.V.. The same ATC class is registered in 11 of our 19 countries.
Checked against CBG-MEB (Netherlands) on
Informational only — not a medical device.
Where it is registered
Dexamethason mit antiinfektiva is registered in 11 of 19 countries.
Countries holding a registration under ATC S01CA01 (dexamethason mit antiinfektiva), each read from that country’s own register.
- This record: Netherlands, from CBG-MEB (Netherlands)
- 7 of them publish a price we can compare per daily dose
Dexamethason mit antiinfektiva · ATC S01CA01
11 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
The record
At a glance
CBG-MEB (Netherlands)- Active substance
- DEXAMETHASONDINATRIUMFOSFAAT + GENTAMICINESULFAAT
- Manufacturer
- URSAPHARM Benelux B.V.
- Country
- Netherlands (NL)
- ATC code
- S01CA01
- ATC class
- Dexamethason mit Antiinfektiva
- Reimbursed
- Not published by this register
- Source register
- CBG-MEB (Netherlands)
- Last checked
- September 29, 2026
Packs & prices · 1
- cbg_meb_id16759
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under S01CA01
Dexamethason mit antiinfektiva, as other registers publish it.
- NetherlandsBradexa 3 mg/ml + 1 mg/ml oogdruppels, suspensieRockmed Pharma B.V.
- PolandBrazoflaminSynoptis Pharma Sp. z o.o.
- BelgiumDe Icol 4 mg/ml - 1 mg/mlViatris Healthcare
- BelgiumDetobra 1 mg/ml - 3 mg/mlViatris Healthcare
- CzechiaDEXA-GENTAMICINURSAPHARM spol. s r.o., Praha
- CzechiaDEXACHLOR
- SwitzerlandDexagenta-POS
- BelgiumDexagenta-Pos 1 mg/ml - 5 mg/mlURSAPHARM Benelux
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/fafecb24-1109-4e9e-92c4-fddf9df1e854 GET /v1/drugs/fafecb24-1109-4e9e-92c4-fddf9df1e854?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Oogdruppels, oplossing",
"route": "Oculair gebruik",
"soort": "RVG",
"source": "cbg_meb",
"smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h16759_smpc.pdf",
"strength": null,
"atc_label": "Dexamethasone And Antiinfectives",
"detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg16759",
"excipients": [
"BENZALKONIUMCHLORIDE",
"DIKALIUMWATERSTOFFOSFAAT 0-WATER (E 340)",
"KALIUMDIWATERSTOFFOSFAAT 0-WATER (E 340)",
"NATRIUMCHLORIDE",
"WATER, GEZUIVERD"
],
"substances": [
"DEXAMETHASONDINATRIUMFOSFAAT",
"GENTAMICINESULFAAT"
],
"leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h16759.pdf",
"authorised_at": "1995/02/21",
"procedure_number": null,
"dispensing_status": "Uitsluitend recept",
"registration_number": "16759",
"additional_monitoring": "N"
}See everything about dexamethason mit antiinfektiva.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.